A borderline form of empty follicle syndrome treated with a double-trigger of gonadotropin-releasing hormone agonist and human chorionic gonadotropin: A case report

Medicine (Baltimore). 2019 Jul;98(27):e16213. doi: 10.1097/MD.0000000000016213.

Abstract

Rationale: The borderline form of empty follicle syndrome (EFS) is a phenomenon where only a few mature or immature oocytes are retrieved despite adequate response to controlled ovarian hyperstimulation (COH). It is a rare phenomenon with an unclear underlying mechanism, and there is currently no effective treatment.

Patient concerns: The patient received 3 assisted reproductive technology cycles, and although her follicular development and estrogen levels were normal during COH, the outcome with respect to the oocytes obtained was unsatisfactory.

Diagnoses: Borderline form of EFS.

Interventions: In the context of undergoing GnRH-antagonist protocol, we implemented a double-trigger with human chorionic gonadotropin (hCG) after 6 hours of gonadotropin-releasing hormone agonist (GnRH-a) administration.

Outcomes: Eleven oocytes were obtained (M I × 3, M II × 8), which underwent in vitro fertilization (IVF). After 18 hours, 7 oocytes showed normal fertilization, with 2 embryos formed 72 hours later (embryo rating, 6C II × 1, 9C II × 1); the embryos were then frozen.

Lessons: Oocyte maturation and ovulation are time-dependent processes, and that different patients require different lengths/intervals of time for treatment. Therefore, the borderline form of EFS, in general, may be treatable, and our novel trigger method provides a new treatment option for such patients in the future.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Chorionic Gonadotropin / pharmacology*
  • Female
  • Fertility Agents, Female / pharmacology*
  • Fertilization in Vitro
  • Gonadotropin-Releasing Hormone / agonists*
  • Humans
  • Oocyte Retrieval
  • Ovarian Hyperstimulation Syndrome / therapy*
  • Ovulation Induction / methods*
  • Pregnancy
  • Reproductive Control Agents / pharmacology

Substances

  • Chorionic Gonadotropin
  • Fertility Agents, Female
  • Reproductive Control Agents
  • Gonadotropin-Releasing Hormone